BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8460105)

  • 1. Crystallographic analysis of the interaction between cyclosporin A and the Fab fragment of a monoclonal antibody.
    Vix O; Rees B; Thierry JC; Altschuh D
    Proteins; 1993 Apr; 15(4):339-48. PubMed ID: 8460105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the mimicry of polysaccharide antigens by anti-idiotypic antibodies. The crystallization, molecular replacement, and refinement to 2.8 A resolution of an idiotope-anti-idiotope Fab complex and of the unliganded anti-idiotope Fab.
    Evans SV; Rose DR; To R; Young NM; Bundle DR
    J Mol Biol; 1994 Sep; 241(5):691-705. PubMed ID: 8071993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional structure of an Fab-peptide complex: structural basis of HIV-1 protease inhibition by a monoclonal antibody.
    Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
    J Mol Biol; 1997 Apr; 267(5):1207-22. PubMed ID: 9150407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure determination of an Fab fragment that neutralizes human rhinovirus 14 and analysis of the Fab-virus complex.
    Liu H; Smith TJ; Lee WM; Mosser AG; Rueckert RR; Olson NH; Cheng RH; Baker TS
    J Mol Biol; 1994 Jul; 240(2):127-37. PubMed ID: 8027997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the liganded anti-gibberellin A(4) antibody 4-B8(8)/E9 Fab fragment.
    Murata T; Fushinobu S; Nakajima M; Asami O; Sassa T; Wakagi T; Yamaguchi I
    Biochem Biophys Res Commun; 2002 Apr; 293(1):489-96. PubMed ID: 12054627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional structures of the Fab fragment of murine N1G9 antibody from the primary immune response and of its complex with (4-hydroxy-3-nitrophenyl)acetate.
    Mizutani R; Miura K; Nakayama T; Shimada I; Arata Y; Satow Y
    J Mol Biol; 1995 Nov; 254(2):208-22. PubMed ID: 7490744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The crystal structure of the antibody N10-staphylococcal nuclease complex at 2.9 A resolution.
    Bossart-Whitaker P; Chang CY; Novotny J; Benjamin DC; Sheriff S
    J Mol Biol; 1995 Nov; 253(4):559-75. PubMed ID: 7473734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A as a model antigen: immunochemical and structural studies.
    Altschuh D
    J Mol Recognit; 2002; 15(5):277-85. PubMed ID: 12447904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.
    Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA
    J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spatial structure of a Fab-fragment of a monoclonal antibody to human interleukin-2 in two crystalline forms at a resolution of 2.2 and 2.9 angstroms].
    Fokin AV; Afonin PV; Mikhaĭlova IIu; Tsygannik IN; Mareeva TIu; Nesmeianov VA; Pangborn W; Lee N; Duax W; Siszak E; Pletnev VZ
    Bioorg Khim; 2000 Aug; 26(8):571-8. PubMed ID: 11040993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anchoring a cationic ligand: the structure of the Fab fragment of the anti-morphine antibody 9B1 and its complex with morphine.
    Pozharski E; Wilson MA; Hewagama A; Shanafelt AB; Petsko G; Ringe D
    J Mol Biol; 2004 Mar; 337(3):691-7. PubMed ID: 15019787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution.
    Mylvaganam SE; Paterson Y; Getzoff ED
    J Mol Biol; 1998 Aug; 281(2):301-22. PubMed ID: 9698550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of an anti-anti-idiotype shows it to be self-complementary.
    Ban N; Day J; Wang X; Ferrone S; McPherson A
    J Mol Biol; 1996 Feb; 255(4):617-27. PubMed ID: 8568901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of an anticholera toxin peptide complex at 2.3 A.
    Shoham M
    J Mol Biol; 1993 Aug; 232(4):1169-75. PubMed ID: 7690406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed analysis of the free and bound conformations of an antibody. X-ray structures of Fab 17/9 and three different Fab-peptide complexes.
    Schulze-Gahmen U; Rini JM; Wilson IA
    J Mol Biol; 1993 Dec; 234(4):1098-118. PubMed ID: 8263915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary crystallographic analysis of a Fab specific for P-glycoprotein with and without bound peptide.
    Vasudevan S; Johns KL; Rose DR
    J Mol Biol; 1994 Sep; 241(5):736-8. PubMed ID: 7915332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of mean force for Syrian hamster prion epitope protein--monoclonal fab 3f4 antibody interaction studies.
    Wang YT; Su ZY; Liao JM; Chen CL
    Eur J Med Chem; 2009 Sep; 44(9):3504-8. PubMed ID: 19304354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the antigen combining site of an anti-dinitrophenyl antibody, ANO2.
    Bassolino-Klimas D; Bruccoleri RE; Subramaniam S
    Protein Sci; 1992 Nov; 1(11):1465-76. PubMed ID: 1303765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rational construction of an antibody against cystatin: lessons from the crystal structure of an artificial Fab fragment.
    Schiweck W; Skerra A
    J Mol Biol; 1997 May; 268(5):934-51. PubMed ID: 9180382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.